Delivery Order SPE2DB20D9127-SPE2DB25FPRF2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (#4600082013) with DMS Pharmaceutical Group valued up to $4,999,999 for the supply of a broad range of pharmaceutical items to military health facilities globally. The delivery order is for the drug Trikafta, used to treat...
- The Defense Logistics Agency awarded a $18,868.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta (a cystic fibrosis treatment medication). The delivery order, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $55,464.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing single-award...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, was issued without a set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on October 27, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order falls...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of the prescription drug Trikafta, and has an ultimate completion date of July 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $18,488.12 for Trikafta 100-50-75 mg/150 mg oral units (84-count). This firm fixed-price delivery order, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a direct fulfillment of pharmaceutical supply needs under the company's existing Indefinite Delivery Contract with DLA. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for $18,488.12 on August 21, 2025. The order, valued at $18,488.12 with a firm fixed-price contract type, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84 count) to be delivered to Park Ridge, Illinois by August 22, 2025. This award was issued without a set-aside designation, enabling DMS Pharmaceutical Group to compete on an open...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on July 14, 2025. The delivery order, which is scheduled for completion by July 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without set-aside designation and represents a single delivery order under DMS...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRF2Delivery Order
The Defense Logistics Agency (DLA) awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg, a cystic fibrosis treatment medication. The delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a targeted pharmaceutical procurement without set-aside designation. DMS Pharmaceutical Group leverages its competitive positioning within the federal market to secure contracts meeting Department of Defense healthcare supply requirements. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders across a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. As a long-standing federal supplier registered in the System for Award Management since 2001, DMS Pharmaceutical Group serves as a critical partner in the Department of Defense's pharmaceutical supply chain, directly distributing prescription medications and pharmacy services to military healthcare sites across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/25/25 |